节点文献

KRAS突变型肺癌作用机制与治疗策略的最新进展

Recent advances in studies of KRAS mutated lung cancer

推荐 CAJ下载
PDF下载
不支持迅雷等下载工具，请取消加速工具后下载。

【作者】胡晓庆；张聿达；陈阳倩；向思琦；言欢；秦浩越；黄哲；张星；马宏志；张琳；曾亮；张永昌；杨农；

【Author】 HU Xiaoqing;ZHANG Yuda;CHEN Yangqian;XIANG Siqi;YAN Huan;QIN Haoyue;HUANG Zhe;ZHANG Xing;MA Hongzhi;ZHANG Lin;ZENG Liang;ZHANG Yongchang;YANG Nong;Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University;Department of Medical Oncology, Graduate Collaborative Training Base of Hunan Cancer Hospital,Hengyang Medical School, University of South China;Department of Biochemistry and Immunology, College of Medical Science, Jishou University;Department of Head and Neck Radiotherapy Ⅱ, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University;Department of Thoracic Radiotherapy Ⅰ, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University;Department of Medical Oncology, Lung Cancer and Gastrointestinal Unit, Hunan Cancer Hospital/the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University;

【通讯作者】张永昌;杨农;

【机构】中南大学湘雅公共卫生学院流行病与卫生统计系；南华大学衡阳医学院湖南省肿瘤医院研究生协作培养基地；吉首大学医学院生物化学与免疫学系医学研究中心；湖南省肿瘤医院头颈放疗二科；湖南省肿瘤医院胸部放疗一科；湖南省肿瘤医院肺胃肠内科；

【摘要】肺癌是全球最常见的恶性肿瘤之一，KRAS是肺癌发生基因突变的重要位点。由于KRAS突变亚型中常缺乏药理学药物靶向的口袋，KRAS突变位点一直被认为是“不可成药”的靶点。本文主要概括了KRAS突变型肺癌的作用机制和KRAS成药所面临的困难，并对KRAS突变的治疗策略和耐药机制的最新进展进行阐述。更多还原

【Abstract】 Lung cancer is one of the worldwide most common malignant tumors, and KRAS is an important gene mutation site in lung cancer. But KRAS has been considered "undruggable" due to the lack of pharmacologically targeted pockets in KRAS mutant subtypes. In this article, we mainly summarized the mechanism of KRAS mutation in lung cancer and the difficulties faced by KRAS drugs. Recent advances in treatment strategies and resistance mechanisms of KRAS-mutated lung cancer were also described.更多还原

【关键词】 KRAS突变；非小细胞肺癌；免疫疗法；靶向治疗； Sotorasib； Adagrasib；
【Key words】 KRAS mutation； Non-small cell lung cancer； Immunotherapy； Targeted therapy； Sotorasib； Adagrasib；

【文献出处】肿瘤药学 ,Anti-tumor Pharmacy , 编辑部邮箱 ,2023年06期

【分类号】R734.2
【下载频次】95

知网节下载

节点文献中：

本文链接的文献网络图示:

本文的引文网络

节点文献